Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
Grant
Adjust height of sidebar
KMap
Grant
A Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Fazirsiran in the Treatment of Alpha-1 Antitrypsin Deficiency?associated Liver Disease With Metavir
Sponsored by PPD Investigator Services, LLC.
Active
$1.6M Funding
5 People
External
Related Topics
clinical trial,
liver disease,
alpha-1 antitrypsin,
treatment,
safety
People
Gustavo Cornejo
(CD)
Senior VP Health Sciences
﹒Research Compliance Administrator II
Kirsten Anderson
(CD)
Senior VP Health Sciences
﹒Research Compliance Administrator IV
Geoffrey Block
Principal Investigator (PI)
Medicine
﹒Clinical Professor, Medicine
Ryan Akhbari
(CD)
Liver Research Institute
﹒Clinical Research Coordinator II
Jason Gass
(CD)
Liver Research Institute
﹒Research Data Support Specialist II